Cavitating lung cancer as response to bevacizumab treatment.
Sección de Imagen Cardiotorácica, Servicio de Radiodiagnóstico, Hospital Universitario La Paz, Madrid, España. Electronic address: luciafernanro@gmail.com.
Lucía
L
Fernández-Rodríguez
Sección de Imagen Cardiotorácica, Servicio de Radiodiagnóstico, Hospital Universitario La Paz, Madrid, España.
Alicia
A
Linares-Beltrán
Sección de Imagen Cardiotorácica, Servicio de Radiodiagnóstico, Hospital Universitario La Paz, Madrid, España.
Isabel
I
Torres-Sánchez
D000230:Adenocarcinoma / Q000000981:diagnostic imaging / Q000188:drug therapy*; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab / Q000008:administration & dosage / Q000494:pharmacology*; D016190:Carboplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000473:pathology; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008875:Middle Aged; D009336:Necrosis; D017239:Paclitaxel / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D047368:Tumor Burden
D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab; D016190:Carboplatin; D017239:Paclitaxel